Melaena following Use of the Cholinesterase Inhibitor Rivastigmine.

Autor: Gareri P; Clinical Pharmacology Unit, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Catanzaro, ItalyOperative Unit ‘Elderly Health Care’, Catanzaro, Italy., Gallelli L, Ferreri Ibbadu G, Lacava R, Russo E, De Sarro G
Jazyk: angličtina
Zdroj: Clinical drug investigation [Clin Drug Investig] 2005; Vol. 25 (3), pp. 215-7.
DOI: 10.2165/00044011-200525030-00008
Databáze: MEDLINE